IN8BIO, INC.

INAB

IN8BIO, INC.

INAB

Insider Sentiment (TTM):

Last Purchase:2023-09-13Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:3,620,359Shares Outstanding:19,467,114Institutional Ownership Pct.:18.60%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	18	22	27	11	13	12	11	4	10	13	21	13
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	3	2	3	3	4
Assets Current	18	23	28	12	14	13	13	7	13	-	25	17
Assets Noncurrent
Property Plant And Equipment Net	2	2	2	2	2	3	3	3	3	3	4	4
Restricted Cash	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Finance Costs Noncurrent Net	-	-	-	-	-	-	-	0	-	-	-	-
Finance Lease Right Of Use Asset	-	0	0	0	1	1	1	1	2	-	1	2
Operating Lease Right Of Use Asset	1	1	2	2	2	3	4	4	4	-	4	4
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	-	0	0
Assets Noncurrent	3	4	4	5	6	7	8	9	10	-	9	10
Assets	22	26	32	17	19	20	21	16	22	-	34	26
Liabilities And Stockhold…
Liabilities
Liabilities Current
Accounts Payable Current	0	0	0	0	0	1	0	1	1	-	1	1
Accrued Liabilities Current	1	1	2	0	1	1	1	1	2	1	3	2
Finance Lease Liability Current	-	0	0	0	0	1	1	1	1	1	1	1
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities Current	2	2	3	2	2	3	3	4	5	-	5	5
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	0	1	0	1	1
Operating Lease Liability Noncurrent	1	1	2	2	2	3	3	3	4	4	3	3
Liabilities Noncurrent	1	1	2	2	2	3	3	4	4	-	3	4
Liabilities	3	3	5	4	4	6	6	7	9	-	9	8
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	-	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	-	0	0
Additional Paid In Capital	169	169	169	149	148	141	136	124	122	-	116	101
Retained Earnings Accumulated Deficit	-151	-146	-141	-136	-132	-127	-122	-115	-108	-	-91	-84
Stockholders Equity	18	23	28	13	15	14	14	9	14	18	25	18
Liabilities And Stockholders Equity	22	26	32	17	19	20	21	16	22	-	34	26
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	-	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	-	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	-	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	490	490	490	490	490	490	490	490	490	490	490	490
Common Stock Shares Issued	10	10	10	5	4	3	2	2	2	-	1	1
Shares Outstanding	10	10	10	5	4	3	2	2	2	-	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	16.87%	-15.00%	-25.00%	-	-	-	-	-	-	-	-	-
2025	-10.30%	-56.97%	-50.71%	2.79%	6.51%	-0.47%	19.28%	34.34%	44.58%	-24.61%	-21.47%	-2.09%
2024	17.82%	-16.14%	-16.93%	-23.10%	-58.19%	-54.68%	-11.71%	-16.86%	-26.86%	-33.19%	-24.78%	-34.51%
2023	-	-	-	-7.83%	-9.57%	-19.13%	-16.24%	36.63%	28.71%	-5.17%	-13.79%	2.59%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.21	10.50	8.82	6.91	7.03	4.30	4.08	1.84	2.66	-	4.57	3.53
Quick Ratio	7.97	10.17	8.57	6.28	6.77	4.02	3.61	1.10	2.15	-	3.95	2.74
Working Capital	16.24M	20.50M	24.72M	10.07M	11.79M	9.77M	9.50M	3.07M	7.92M	-	19.23M	11.86M
Leverage & Debt
Debt to Equity	0.18	0.15	0.17	0.27	0.27	0.43	0.45	0.86	0.65	-	0.35	0.48
Debt Ratio	0.16	0.13	0.15	0.21	0.21	0.30	0.31	0.46	0.39	-	0.26	0.32
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.96	-0.97	-4.44	-4.55	-5.80	-10.65	-17.05	-20.21	-20.40	-21.54	-30.17	-28.76
Free Cash Flow Per Share TTM	-0.64	-0.75	-2.91	-2.53	-3.41	-7.52	-13.57	-15.88	-15.73	-16.58	-23.88	-25.56
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-21.86%	-30.79%	-36.13%	-35.19%	-25.25%	-11.66%	1.43%	5.52%	5.00%	3.82%	5.21%	7.04%
EPS Growth (1Y)	-83.47%	-90.84%	-73.94%	-77.47%	-71.56%	-50.55%	-43.48%	-29.73%	-36.47%	-40.68%	-26.13%	-26.50%
Valuation Metrics
P/E TTM	-1.47	-1.52	-0.53	-0.48	-0.36	-0.47	-0.45	-0.40	-1.25	-1.64	-1.37	-1.09
P/B TTM	1.49	1.26	0.37	0.75	0.56	0.92	0.95	1.49	2.92	2.91	1.65	1.85
Market Cap	27.45M	28.81M	10.24M	9.85M	8.61M	12.83M	13.76M	12.78M	39.82M	51.03M	41.17M	32.77M
Enterprise Value	9.32M	6.84M	-16.78M	-708.23K	-4.36M	1.43M	3.36M	9.72M	30.76M	38.79M	20.85M	21.08M
Calculated Values
Free Cash Flow TTM	-12.53M	-14.54M	-12.71M	-11.48M	-14.07M	-19.37M	-24.22M	-25.04M	-24.64M	-23.91M	-23.75M	-26.85M
Net Debt	-18.13M	-21.97M	-27.02M	-10.56M	-12.97M	-11.39M	-10.40M	-3.05M	-9.06M	-12.24M	-20.32M	-11.70M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-09-13Purchase

Owner: Graff, Jeremy R.

Title: -

Shares: 2,500

Price/Share: $0.95

Value: $2,375.00

Shares Owned: 2,500

Relationship: Director

Ownership: Direct

2023-08-25Purchase

Owner: Mccall, Patrick

Title: Chief Financial Officer

Shares: 1,000

Price/Share: $1.03

Value: $1,030.00

Shares Owned: 6,263

Relationship: Officer

Ownership: Direct

2023-08-24Purchase

Owner: Ho, William Tai-Wei

Title: President and CEO

Shares: 23,800

Price/Share: $1.05

Value: $24,990.00

Shares Owned: 2,339,545

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2022-12-12Purchase

Owner: Bios, Fund Iii Qp, Lp, Bi…

Title: -

Shares: 75,001

Price/Share: $2.48

Value: $186,002.48

Shares Owned: 3,727,597

Relationship: Director,TenPercentOwner

Ownership: Indirect

2022-12-12Purchase

Owner: Kreis, Leslie W., Cavu Ma…

Title: -

Shares: 75,001

Price/Share: $2.48

Value: $186,002.48

Shares Owned: 3,727,597

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-09-13	Graff, Jeremy R.	Director	-	Direct	Purchase	2,500	0.95	$2,375.00	2,500	4
2023-08-25	Mccall, Patrick	Officer	Chief Financial Officer	Direct	Purchase	1,000	1.03	$1,030.00	6,263	4
2023-08-24	Ho, William Tai-Wei	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	23,800	1.05	$24,990.00	2,339,545	4
2022-12-12	Bios, Fund Iii Qp, Lp, Bi…	Director,TenPercentOwner	-	Indirect	Purchase	75,001	2.48	$186,002.48	3,727,597	4
2022-12-12	Kreis, Leslie W., Cavu Ma…	Director,TenPercentOwner	-	Indirect	Purchase	75,001	2.48	$186,002.48	3,727,597	4
2022-09-28	Bios, Equity Partners Ii,…	Director,TenPercentOwner	-	Indirect	Purchase	25,000	2.02	$50,500.00	3,670,545	4
2022-09-28	Bios, Fund Ii Nt, Lp, Bio…	Director,TenPercentOwner	-	Indirect	Purchase	25,000	2.02	$50,500.00	3,670,545	4
2022-08-29	Cavu, Advisors, Llc, Krei…	Director,TenPercentOwner	-	Indirect	Purchase	40,000	2.02	$80,800.00	3,651,528	4
2022-08-29	Bios, Fund Ii Qp, Lp, Fle…	Director,TenPercentOwner	-	Indirect	Purchase	40,000	2.02	$80,800.00	3,651,528	4
2022-08-17	Bios, Fund Ii Nt, Lp, Bio…	Director,TenPercentOwner	-	Indirect	Purchase	50,000	1.93	$96,500.00	3,612,569	4
2022-08-17	Cavu, Management, Lp, Bio…	Director,TenPercentOwner	-	Indirect	Purchase	50,000	1.93	$96,500.00	3,612,569	4
2022-08-16	Rochlin, Kate	Officer	Chief Operating Officer	Direct	Purchase	5,263	1.90	$9,999.70	5,263	4
2022-08-16	Ho, William Tai-Wei	Director,Officer	President, CEO and CFO	Direct	Purchase	26,315	1.90	$49,998.50	2,315,745	4
2022-08-16	Goswami, Trishna	Officer	Chief Medical Officer	Direct	Purchase	2,631	1.90	$4,998.90	2,631	4
2022-08-16	Mccall, Patrick	Officer	Chief Financial Officer	Direct	Purchase	5,263	1.90	$9,999.70	5,263	4
2022-08-16	Transcend, Partners Oppor…	Director,TenPercentOwner	-	Indirect	Purchase	789,473	1.90	$1,499,998.70	4,111,958	4
2022-08-16	Brandt, Peter C.	Director	-	Direct	Purchase	105,263	1.90	$199,999.70	182,473	4
2022-08-16	Greenwood, Luba	Director	-	Direct	Purchase	526	1.90	$999.40	7,826	4
2022-08-16	Lamb, Lawrence	Officer	EVP and CSO	Direct	Purchase	526	1.90	$999.40	99,730	4
2022-08-16	Roemer, Alan S.	Director	-	Direct	Purchase	26,315	1.90	$49,998.50	55,989	4
2022-08-16	Bios, Advisors Gp, Llc, B…	Director,TenPercentOwner	-	Indirect	Purchase	1,773,684	1.90	$3,369,999.60	3,574,534	4
2022-08-16	Bios, Fund Ii, Lp, Bios E…	Director,TenPercentOwner	-	Indirect	Purchase	1,773,684	1.90	$3,369,999.60	3,574,534	4
2021-08-03	Transcend, Partners Oppor…	Director,TenPercentOwner	-	Indirect	Purchase	100,000	10.00	$1,000,000.00	3,322,485	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

18.60%

Inst. Shares: 3,620,359

Shares Outstanding: 19,467,114

2025-12-31

73.98%

Inst. Shares: 3,236,182

Shares Outstanding: 4,374,328

2025-09-30

15.29%

Inst. Shares: 693,655

Shares Outstanding: 4,537,683

2025-06-30

14.29%

Inst. Shares: 588,817

Shares Outstanding: 4,119,153

2025-03-31

28.01%

Inst. Shares: 721,394

Shares Outstanding: 2,575,325

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	3,620,359	19,467,114	18.60%
2025-12-31	3,236,182	4,374,328	73.98%
2025-09-30	693,655	4,537,683	15.29%
2025-06-30	588,817	4,119,153	14.29%
2025-03-31	721,394	2,575,325	28.01%
2024-12-31	999,240	1,784,890	55.98%
2024-09-30	251,802	1,577,363	15.96%
2024-06-30	257,453	1,566,951	16.43%
2024-03-31	283,295	1,441,468	19.65%
2023-12-31	285,133	994,502	28.67%
2023-09-30	82,478	1,050,475	7.85%
2023-06-30	76,837	948,129	8.10%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

IN8BIO, INC. (INAB) — SEC Financial Statements & Analysis

IN8BIO, INC. (INAB) is a biological products, (no diagnostic substances) company, incorporated in DE. IN8BIO, INC. trades on Nasdaq as: INAB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IN8BIO, INC. reported a Debt-to-Equity ratio of 0.18x, a Price-to-Book (P/B) ratio of 1.49x (TTM), at a market cap of $27.45M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.18x
P/B TTM: 1.49x
Market Cap: $27.45M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IN8BIO, INC. in?

IN8BIO, INC. (INAB) operates in the Biological Products, (No Diagnostic Substances) industry.

What is INAB's market cap?

IN8BIO, INC. (INAB) has a market capitalization of $27.45M as of 2026-06-30.

What exchange does INAB trade on?

IN8BIO, INC. (INAB) trades on the Nasdaq.

Where is IN8BIO, INC. incorporated?

IN8BIO, INC. is incorporated in DE.

IN8BIO, INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

IN8BIO, INC. (INAB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

IN8BIO, INC. (INAB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.